Impel Pharmaceuticals Inc.
USD0.04
-0.01 (-27.27%)
CEO
Leonard S. Paolillo
IPO Date
2021-04-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.04
Prev. Close
$0.06
Day Low
$0.02
Day High
$0.05
52W Low
$0.02
52W High
$4.20
Market Cap
$0.00B
Volume
0.72M
| -1.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 34.3% | -379.8% | -0.06 | 0.78 | -4.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 45.6% | -99.0% | 0.00 | 4.75 | -4.7 |
| -1.0 |
| 31 Mar 2023 | Q1 | 47.7% | -883.6% | 53.0% | -59.7% | -0.73 | 2.33 | -0.2 |
| 31 Dec 2022 | Q4 | 55.7% | -725.1% | 82.2% | -41.0% | -1.16 | 3.60 | -0.6 |
| 30 Sept 2022 | Q3 | 51.1% | -1328.8% | 183.7% | -38.9% | -2.26 | 4.97 | -0.7 |
| 30 Jun 2022 | Q2 | 38.0% | -1049.9% | -752.6% | -24.4% | 12.86 | 6.25 | -1.8 |
| 31 Mar 2022 | Q1 | 41.3% | -1774.7% | -113.6% | -21.1% | 1.81 | 5.93 | -1.2 |
| 31 Dec 2021 | Q4 | 23.6% | -4288.0% | -47.1% | -25.3% | 0.56 | 5.93 | -2.0 |
| 30 Sept 2021 | Q3 | -174.7% | -27495.6% | -33.0% | -20.6% | 0.39 | 7.25 | -2.5 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -30.2% | -22.4% | 0.17 | 7.28 | -2.0 |